These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 25772939)

  • 21. Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up.
    Yung AR; Nelson B; Stanford C; Simmons MB; Cosgrave EM; Killackey E; Phillips LJ; Bechdolf A; Buckby J; McGorry PD
    Schizophr Res; 2008 Oct; 105(1-3):10-7. PubMed ID: 18765167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Social environmental risk factors for transition to psychosis in an Ultra-High Risk population.
    O'Donoghue B; Nelson B; Yuen HP; Lane A; Wood S; Thompson A; Lin A; McGorry P; Yung AR
    Schizophr Res; 2015 Feb; 161(2-3):150-5. PubMed ID: 25439392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Childhood trauma and clinical outcome in patients at ultra-high risk of transition to psychosis.
    Kraan T; van Dam DS; Velthorst E; de Ruigh EL; Nieman DH; Durston S; Schothorst P; van der Gaag M; de Haan L
    Schizophr Res; 2015 Dec; 169(1-3):193-198. PubMed ID: 26585219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial.
    Bolt LK; Amminger GP; Farhall J; McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Allott KA
    Schizophr Res; 2019 Apr; 206():67-74. PubMed ID: 30558978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative and qualitative symptomatic differences in individuals at Ultra-High Risk for psychosis and healthy controls.
    Velthorst E; Derks EM; Schothorst P; Becker H; Durston S; Ziermans T; Nieman DH; de Haan L
    Psychiatry Res; 2013 Dec; 210(2):432-7. PubMed ID: 23938166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychosis-like experiences and distress among adolescents using mental health services.
    Kline E; Thompson E; Bussell K; Pitts SC; Reeves G; Schiffman J
    Schizophr Res; 2014 Feb; 152(2-3):498-502. PubMed ID: 24411529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stigma as a stressor and transition to schizophrenia after one year among young people at risk of psychosis.
    Rüsch N; Heekeren K; Theodoridou A; Müller M; Corrigan PW; Mayer B; Metzler S; Dvorsky D; Walitza S; Rössler W
    Schizophr Res; 2015 Aug; 166(1-3):43-8. PubMed ID: 26036814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Twelve-month psychosis-predictive value of the ultra-high risk criteria in children and adolescents.
    Armando M; Pontillo M; De Crescenzo F; Mazzone L; Monducci E; Lo Cascio N; Santonastaso O; Pucciarini ML; Vicari S; Schimmelmann BG; Schultze-Lutter F
    Schizophr Res; 2015 Dec; 169(1-3):186-192. PubMed ID: 26526751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain structure in people at ultra-high risk of psychosis, patients with first-episode schizophrenia, and healthy controls: a VBM study.
    Nenadic I; Dietzek M; Schönfeld N; Lorenz C; Gussew A; Reichenbach JR; Sauer H; Gaser C; Smesny S
    Schizophr Res; 2015 Feb; 161(2-3):169-76. PubMed ID: 25497442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of a two-stage strategy using the 16-item Prodromal Questionnaire (PQ16/fPQ16) and the Comprehensive Assessment of At Risk Mental States (CAARMS) in the early detection of Ultra High Risk (UHR) patients in Lebanon: a cross-sectional pilot study.
    Mourad M; Atallah EP; Raad G; Haddad R; Richa S
    Encephale; 2024 Feb; 50(1):40-47. PubMed ID: 36717331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High remission rates from an initial ultra-high risk state for psychosis.
    Simon AE; Umbricht D
    Schizophr Res; 2010 Feb; 116(2-3):168-72. PubMed ID: 19854621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms.
    Addington J; Liu L; Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; McGlashan TH
    J Nerv Ment Dis; 2015 May; 203(5):328-35. PubMed ID: 25919383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomes.
    Youn S; Phillips LJ; Amminger GP; Berger G; Chen EYH; de Haan L; Hartmann JA; Hickie IB; Lavoie S; Markulev C; McGorry PD; Mossaheb N; Nieman DH; Nordentoft M; Riecher-Rössler A; Schäfer MR; Schlögelhofer M; Smesny S; Thompson A; Verma S; Yuen HP; Yung AR; Nelson B
    Schizophr Res; 2020 Feb; 216():255-261. PubMed ID: 31866077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Declining transition rates to psychosis: the role of diagnostic spectra and symptom overlaps in individuals with attenuated psychosis syndrome.
    Simon AE; Umbricht D; Lang UE; Borgwardt S
    Schizophr Res; 2014 Nov; 159(2-3):292-8. PubMed ID: 25263994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parental socioeconomic status and prognosis in individuals with ultra-high risk for psychosis: A 2-year follow-up study.
    Hur JW; Choi SH; Yun JY; Chon MW; Kwon JS
    Schizophr Res; 2015 Oct; 168(1-2):56-61. PubMed ID: 26213342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salivary cortisol in early psychosis: New findings and meta-analysis.
    Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
    Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of the Arabic version of the Comprehensive Assessment of At Risk Mental States (CAARMS) in Tunisian adolescents and young adults.
    Braham A; Bannour AS; Ben Romdhane A; Nelson B; Bougmiza I; Ben Nasr S; Elkissi Y; Ben Hadj Ali B
    Early Interv Psychiatry; 2014 May; 8(2):147-54. PubMed ID: 23347425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Childhood maltreatment and transition to psychotic disorder independently predict long-term functioning in young people at ultra-high risk for psychosis.
    Yung AR; Cotter J; Wood SJ; McGorry P; Thompson AD; Nelson B; Lin A
    Psychol Med; 2015 Dec; 45(16):3453-65. PubMed ID: 26166153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between psychosocial functioning and resilience and negative symptoms in individuals at ultra-high risk for psychosis.
    Kim KR; Song YY; Park JY; Lee EH; Lee M; Lee SY; Kang JI; Lee E; Yoo SW; An SK; Kwon JS
    Aust N Z J Psychiatry; 2013 Aug; 47(8):762-71. PubMed ID: 23661784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.